Because we have shown that TIPE2 suppresses IL-17A production by T cells during the development of IMQ-induced psoriasis (Figure 2B), the percentage (Figure 4C) and absolute number (Figure 4D) of CD3+IL-17A+ T cells was significantly increased in the blood and ILN as expected. The gene discussed is TIPE2; the disease is psoriasis.